Nuveen New York Quality Municipal Income Fund (NAN) Research
The Nuveen New York Quality Municipal Income Fund, formerly known as the Nuveen New York Dividend Advantage Municipal Fund, is a closed-end mutual fund concentrating on fixed-income investments. This fund was established by Nuveen Investments, Inc., and receives joint management from Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. Its investment strategy involves allocating capital primarily within New York's fixed income markets, focusing specifically on municipal bonds that carry a rating of Baa or higher. The portfolio is constructed using a bottom-up stock-picking approach, guided by thorough fundamental analysis. To assess its performance, the fund benchmarks against both the Standard & Poor's New York Municipal Bond Index and the Standard & Poor's National Municipal Bond Index. It commenced operations on May 26, 1999, and is domiciled in the United States.
Market snapshot
- Symbol
- NAN
- Price
- $11.60
- Day change
- +0.43%
- Market cap
- $370.6M
- P/E ratio
- -15.47x
- 52-week range
- 10.79-11.67
- Sector
- Financial Services
- Industry
- Asset Management - Income
Peer companies
- AllianceBernstein National Municipal Income Fund, Inc. (AFB)
- Nuveen Global High Income Fund (JGH)
- Nuveen Real Asset Income and Growth Fund (JRI)
- BlackRock MuniYield New York Quality Fund, Inc. (MYN)
- Nuveen California Municipal Value Fund (NCA)
- Virtus Convertible & Income Fund (NCV)
- Nuveen Pennsylvania Quality Municipal Income Fund (NQP)
- PIMCO Income Strategy Fund (PFL)
Recent insider activity
- BANK OF AMERICA CORP /DE/ — P-Purchase (3000 shares) on 2026-05-19
- BANK OF AMERICA CORP /DE/ — S-Sale (3000 shares) on 2026-05-19
- Castro Joseph — trade (0 shares) on 2025-10-16
- BANK OF AMERICA CORP /DE/ — P-Purchase (1000 shares) on 2025-12-08
- BANK OF AMERICA CORP /DE/ — S-Sale (1000 shares) on 2025-12-08
Open Nuveen New York Quality Municipal Income Fund (NAN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.